Ferring licenses Enteris Peptelligence to turn injectable into oral drug
Ferring is the third company in a week which will use Enteris BioPharma’s Peptelligence engineering platform for small molecules to develop oral formulations.
Ferring is the third company in a week which will use Enteris BioPharma’s Peptelligence engineering platform for small molecules to develop oral formulations.
The 24-bed clinical research unit in Las Vegas supports PPD’s Phase I and early development clinical research capabilities.
Almac Group has launched a GDP-compliant web-based platform, TempEZ, to provide customers with a single database to store temperature data from the manufacturing stage to patient administration.
Beximco Pharmaceuticals Limited has partnered with BioCare Manufacturing Sdn Bhd to make generic drugs for the Malaysian market.
Aurinia Pharmaceuticals Inc. will use the CRO Worldwide Clinical Trials’ services for its Phase III trial for Lupus nephritis.
SCOPE Summit
Greenphire is now offering Single Sign-On (SSO) through Exostar’s identity and access management platform.